Yahoo Web Search

Search results

1. • Q2 2025 Earnings Estimate for Bristol-Myers Squibb Issued By Zacks Research (NYSE:BMY)

     ETF DAILY NEWS· 14 hours ago

     Bristol-Myers Squibb (NYSE:BMY – Free Report) – Investment analysts at Zacks Research raised their Q2 2025 earnings estimates for shares of Bristol-Myers Squibb in a research report issued on ...

2. • Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%

     ETF DAILY NEWS· 3 days ago

     Shares of Bristol-Myers Squibb (NYSE:BMY – Get Free Report) fell 1.1% during trading on Thursday . The company traded as low as $41.58 and last traded at $41.89. 3,501,801 shares changed hands ...

3. • 

     Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?

     Simply Wall St. via Yahoo Finance· 5 days ago

     Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to...

4. • 

     Bristol Myers, Sanofi Liability in Hawaii Plavix Case Grows to $916 Million

     Insurance Journal· 5 days ago

     A judge in Hawaii on Tuesday ordered Bristol Myers Squibb and Sanofi to pay more than $916 million...

5. • Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income...

     Morningstar· 6 days ago

     Bristol Myers Squibb (NYSE: BMY) today announced ASPIRE (Accessibility, Sustainability, Patient-centric, Impact, Responsibility and Equity), a 10-year strategy to advance access to our innovative ...

6. • Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology...

     Morningstar· 5 days ago

     Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting Consistent with short-term studies, KarXT was not associated with clinically meaningful changes in movement disorder scale scores and a

7. • 

     This Unpopular Dividend Stock Is a Buy

     The Motley Fool via AOL· 5 days ago

     Dividend stocks are an important anchor for well-balanced portfolios. Regular cash distributions can buffer a portfolio against market volatility and...

8. • 

     Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend...

     Benzinga· 4 hours ago

     Loading... Loading... During times of turbulence and uncertainty in the markets, even when markets...

9. • 

     Pipeline Moves: Phase III AML trial fails to meet primary endpoint

     Clinical Trials Arena via Yahoo Finance· 8 hours ago

     This week on Pipeline Moves, we kick off by looking at a Phase III trial of GlycoMimetics’...

10. • 

      ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC

      Clinical Trials Arena via Yahoo Finance· 3 hours ago

      US-based Rakuten Medical has announced positive interim data from the Phase Ib/II trial of its...